Detalhe da pesquisa
1.
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib.
Value Health
; 26(2): 193-203, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229359
2.
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis.
Value Health
; 25(8): 1428-1438, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248467
3.
Supporting a review of the benefits package of the National Health Insurance Scheme in Ghana.
Cost Eff Resour Alloc
; 20(1): 32, 2022 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842698
4.
Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands.
Mol Diagn Ther
; 28(3): 319-328, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616205
5.
Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems.
Per Med
; 20(4): 357-374, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577962
6.
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation.
Per Med
; 20(4): 305-319, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37623911
7.
Cost-effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries.
Per Med
; 20(4): 321-338, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746727
8.
Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies.
Per Med
; 20(4): 401-411, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694556
9.
Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK.
Per Med
; 20(4): 339-355, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665240
10.
Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries.
Per Med
; 20(4): 387-399, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665262
11.
Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young.
Per Med
; 20(4): 375-385, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694384
12.
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.
Appl Health Econ Health Policy
; 20(4): 501-524, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35368231
13.
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine.
Pharmacoeconomics
; 39(7): 771-788, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860928